Royalty Pharma plc - Class A (RPRX) Stock Price and News

Actionable insights straight to your inbox

Repros Jumps on Positive Drug Trials

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on.

2 MIN READ
09.17.2013

Why These Stocks Will Suffer From SAC Capital’s Legal Woes

The long rise and snowballing decline of SAC Capital Advisors LP has been one of the bigger stories of this year. The legendary investment fund began 2013 with $15 billion in assets, with $6

3 MIN READ
08.21.2013

Thoughts from the Frontline: Austerity is a Four-Letter French Word

The France that I see as I look out from the bullet train today is far different from the France I see when I survey the economic data. Going from Marseilles to Paris, the countryside is

7 MIN READ
06.25.2013

10 Investments That Rose Against the Sell-Off

June 20 saw one of the biggest sell-offs in recent history on the heels of the Fed’s concerns. So we decided to look at the 10 investments that fared the best in a rough climate. We found five

3 MIN READ
06.21.2013

Dow Hits New All-Time High as Stocks Hold on to Gains After Late Surge

The Dow Jones Industrial Average closed at a new all-time high on Tuesday, up 0.41 percent to 14,673.46, and at one point, reaching 14,716.46 before cooling off.Tech stocks led the way, guided by

2 MIN READ
04.9.2013

Shares of Repros Therapeutics Up on Low Testosterone Drug Trials

Shares of Repros Therapeutics (RPRX) are cruising higher in Thursday trading following the Woodland, Texas-based drug maker reporting on Wednesday that top-line results from the first phase 3

2 MIN READ
03.28.2013

Repros Jumps on Positive Drug Trials

Why These Stocks Will Suffer From SAC Capital’s Legal Woes

Thoughts from the Frontline: Austerity is a Four-Letter French Word

10 Investments That Rose Against the Sell-Off

Dow Hits New All-Time High as Stocks Hold on to Gains After Late Surge

Shares of Repros Therapeutics Up on Low Testosterone Drug Trials

Sign up For our Newsletter

CHANNELS

ABOUT